LLY

722.13

-3.25%↓

JNJ

146.57

-1.49%↓

UNH

312.79

-2.04%↓

ABBV

179.89

-4.64%↓

NVO

64.75

-0.87%↓

LLY

722.13

-3.25%↓

JNJ

146.57

-1.49%↓

UNH

312.79

-2.04%↓

ABBV

179.89

-4.64%↓

NVO

64.75

-0.87%↓

LLY

722.13

-3.25%↓

JNJ

146.57

-1.49%↓

UNH

312.79

-2.04%↓

ABBV

179.89

-4.64%↓

NVO

64.75

-0.87%↓

LLY

722.13

-3.25%↓

JNJ

146.57

-1.49%↓

UNH

312.79

-2.04%↓

ABBV

179.89

-4.64%↓

NVO

64.75

-0.87%↓

LLY

722.13

-3.25%↓

JNJ

146.57

-1.49%↓

UNH

312.79

-2.04%↓

ABBV

179.89

-4.64%↓

NVO

64.75

-0.87%↓

Search

Baxter International Inc

Aperta

SettoreSettore sanitario

30.45 -2.87

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

30.22

Massimo

31.53

Metriche Chiave

By Trading Economics

Entrata

614M

126M

Vendite

-128M

2.6B

P/E

Media del settore

124.8

56.602

EPS

0.55

Rendimento da dividendi

2.21

Margine di Profitto

4.8

Dipendenti

38,000

EBITDA

136M

-40M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+19.07% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

2.21%

2.45%

Utili prossimi

5 ago 2025

Prossima data del Dividendo

1 lug 2025

Prossima data del' Ex Dividendo

30 mag 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

647M

16B

Apertura precedente

33.32

Chiusura precedente

30.45

Notizie sul Sentiment di mercato

By Acuity

41%

59%

180 / 382 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Baxter International Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 mag 2025, 23:20 UTC

Utili

Aristocrat Leisure Boosts Half-Year Dividend, Keeps Focus on M&A

13 mag 2025, 23:48 UTC

Discorsi di Mercato

Gold Edges Higher, Supported by Signs of Mild U.S. Inflation -- Market Talk

13 mag 2025, 23:43 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

13 mag 2025, 23:43 UTC

Discorsi di Mercato

Nikkei May Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

13 mag 2025, 23:24 UTC

Discorsi di Mercato
Utili

Global Equities Roundup: Market Talk

13 mag 2025, 23:24 UTC

Discorsi di Mercato
Utili

Aristocrat's 1H Result Falls Short, Jefferies Says -- Market Talk

13 mag 2025, 22:58 UTC

Utili

Table: Samsung Fire & Marine 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mag 2025, 22:58 UTC

Utili

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mag 2025, 22:58 UTC

Utili

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Op Pft KRW792.36B Vs Op KRW897.06B

13 mag 2025, 22:58 UTC

Utili

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Rev KRW6.106T Vs KRW5.507T

13 mag 2025, 22:38 UTC

Utili

Aristocrat: Continues to Actively Pursue Strategic M&A Activities

13 mag 2025, 22:38 UTC

Utili

Aristocrat: Remains Committed to Capital Management Strategy, Ongoing Share Buy-Back Program

13 mag 2025, 22:37 UTC

Utili

Aristocrat: Expects More Operating Momentum in 2H Amid Product Rollout, Technology Initiatives

13 mag 2025, 22:36 UTC

Utili

Aristocrat: Sees Accelerating Performance at Interactive Unit Toward FY 2029 US$1 Bln Revenue Target

13 mag 2025, 22:35 UTC

Utili

Aristocrat: Expects Continued Market Share Gains from Gaming Unit

13 mag 2025, 22:34 UTC

Utili

Aristocrat: Expects to Deliver NPATA Growth Over the Full Year on a Constant Currency Basis

13 mag 2025, 22:33 UTC

Utili

Aristocrat: Interactive Business Delivered Strong Revenue Growth

13 mag 2025, 22:33 UTC

Utili

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

13 mag 2025, 22:33 UTC

Utili

Aristocrat: Product Madness' Key Social Casino Franchises Continued to Outperform

13 mag 2025, 22:30 UTC

Utili

Aristocrat Interim Dividend 44 Australian Cents/Share

13 mag 2025, 22:30 UTC

Utili

Aristocrat 1H Statutory Net Profit from Continuing Operations A$511 Mln, Down 21.6%

13 mag 2025, 22:29 UTC

Utili

Aristocrat 1H Normalized Operating Revenue A$3 Bln, Up 8.7%

13 mag 2025, 22:28 UTC

Utili

Aristocrat 1H Normalized Net Profit A$733 Mln, Up 5.6%

13 mag 2025, 21:15 UTC

Utili

Nu Holdings 1Q Rev $3.2B >NU

13 mag 2025, 21:03 UTC

Notizie principali

GOP Mega Bill's Details Are Out. Now the Fighting Begins. -- WSJ

13 mag 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

13 mag 2025, 20:32 UTC

Utili

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13 mag 2025, 20:31 UTC

Utili

Alcon 1Q Sales $2.45B >ALC.EB

13 mag 2025, 20:30 UTC

Utili

Alcon 1Q Rev $2.47B >ALC.EB

13 mag 2025, 20:30 UTC

Utili

Alcon 1Q EPS 70c >ALC.EB

Confronto tra pari

Modifica del prezzo

Baxter International Inc Previsione

Obiettivo di Prezzo

By TipRanks

19.07% in crescita

Previsioni per 12 mesi

Media 37.09 USD  19.07%

Alto 44 USD

Basso 28 USD

Basato su 13 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Baxter International Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

13 ratings

5

Acquista

7

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

30.475 / 31.345Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

180 / 382 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.